Clinical Trial Update: SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating short-course radiotherapy plus chemotherapy and targeted immunotherapy as a neoadjuvant strategy for high-risk pMMR/MSS rectal cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Adenocarcinoma, High-Risk Cancer | Phase 3 | Status: NOT_YET_RECRUITING